This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Ampsource Biopharma Shanghai Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: **Jiangjiang Hu: Innovator in Antibody Research**
Introduction: **Jiangjiang Hu** is a prominent inventor based in **Chengdu, CN**, recognized for his significant contributions to the field of biopharmaceuticals. His innovative approach towards antibody development serves as a vital step in addressing complex medical challenges.
Latest Patents: Jiangjiang Hu's notable patent, titled *Antibody against TIM-3 and application thereof*, encompasses a groundbreaking antibody targeting human TIM-3. This invention also includes a nucleic acid molecule that encodes the antibody, an expression vector for its production, and a host cell for expression. Furthermore, it outlines a pharmaceutical composition containing the antibody or its fragments, along with its application for creating a medicine aimed at preventing and treating various diseases, including tumors, infectious diseases, and autoimmune conditions.
Career Highlights: Jiangjiang Hu is currently affiliated with **Ampsource Biopharma Shanghai Inc.**, where his expertise is pivotal in advancing their scientific endeavors. His work is characterized by a commitment to innovation and improving healthcare outcomes.
Collaborations: His collaborative efforts with esteemed colleagues, including **Qiang Li** and **Tongtong Xue**, have enriched the research environment, fostering a culture of innovation and shared knowledge within the organization.
Conclusion: In summary, Jiangjiang Hu's contributions to antibody research through his patent on TIM-3 demonstrate the potential of innovative solutions in the biopharmaceutical landscape. His work not only advances scientific understanding but also holds promise for significant therapeutic applications in modern medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile